virological response
Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
... (virological response) and safety (adverse events and drug discontinuation) were collected from the medical records of patients with genotype 1 HCV infection in triple therapy with either boceprevir plus ...
6
Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy
... on virological response in patients treated with a particular drug regimen are based on in vitro informations or on the virological response reported in patients who switched to that partic- ...
9
Satisfactory virological response and fibrosis improvement of sofosbuvir based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real world cohort study
... Among the group of SOF + DCV, 28 cases were treated for 12 weeks and 29 cases received therapy for 24 weeks. Whereas, in group of SOF + DCV + RBV, 21 cirrhotic pa- tients underwent 24-week treatment, and 3 cases received ...
8
Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy
... sustained virological response in Pakistan ...treatment response even before the onset of treatment and tailoring the treatment regi- men according to the predicted treatment ...
8
Improved Sustained Virological Response Following Treatment with Pegylated Interferon Alpha 2b Compared with Alpha 2a, Both with Ribavirin, for Chronic Hepatitis C Infection with Genotypes 2 and 3
... Purpose: The optimal formulation of pegylated interferon α (PEG-IFα) as a part of combination therapy with ribavirin (RBV) is uncertain for patients infected with hepatitis C Genotypes 2 and 3. Methods: A multivariate ...
7
Acute HIV infection presenting as hemophagocytic syndrome with an unusual serological and virological response to ART
... its virological and immunological aspects are not completely ...and virological response, characterized by an impaired HIV- antibody production and a 12 month time frame to reach an undetectable ...
5
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
... the response to IFN-α-based ...rapid virological re- sponse (RVR), which is defined as undetectable HCV RNA by Week 4 of therapy, are very likely to achieve ...the virological response at ...
8
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIV
... (rapid virological response, or RVR). Sustained virological response (SVR) is rather defined as an undetectable HCV-RNA level (<50 IU/ml) 24 weeks after treatment withdrawal, and it ...
9
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
... All patients received Peg-IFN α-2a at 180 μg/week or PEG-INF α-2b at 1.5 μg/kg/week combined with riba- virin at 1000 mg/day if the body weight was < 75 Kg or 1200 mg/day if the body weight was > 75 kg. The dose of ...
7
Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana
... This virological suppression on first line ARVs is very encouraging and comes close to the new global UNAIDS target which indicates that by the year 2020, at least 90% of all clients initiated on ART should have ...
7
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
... The present study was part of a randomized controlled trial evaluating two nutritional supplements in adult patients initiating ART in Ethiopia, which was registered at www.controlled-trials.com (ISRCTN32453477). There ...
7
SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
... Historically, Phase II and Phase III clinical trials of hepatitis C virus (HCV) treatments have defined sustained virological response (SVR) as an undetectable HCV RNA 24 weeks after end of treatment ...
10
Older age does not influence CD4 cell recovery in HIV 1 infected patients receiving Highly Active Anti Retroviral Therapy
... Early work also demonstrated a positive association between age and the plasma HIV-1-RNA copy number at the time of identification of HIV-1 serostatus among recently diagnosed older HIV-1 positive individuals [41]. ...
11
Predicting the duration of antiviral treatment needed to suppress plasma HIV 1 RNA
... of response to antiretroviral ...of response to treatment with a series of virological and immunological measures, including levels of viral load in blood and lymph node, percent of CD4 T cells in ...
7
Monitoring the Treatment of Hepatitis C Viral Infection by Molecular Techniques
... Sustained virological response (SVR) was achieved in this study by 40/57 pa- tients (71.42%) that vary from results reported by Martin-Carbonero et al . [20] who showed 32.6% SVR, and Wong and Lee [10] ...
10
Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
... A retrospective chart review evaluated 35 patients with pre- vious treatment failure who were treated with ETV – TDF combination therapy for a minimum of 6 months. Complete patient demographics are shown in table 1. ...
8
High versus standard doses interferon alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10 year cohort study
... unfavorable virological risk factors are unchangeable, tailored regimens of IFN with or without ribavirin combination therapy according to the virological status are the only way to improve the efficiency ...
10
Prevention of atherosclerosis in patients living with HIV
... and virological response markers and an infl ammatory marker (hs-CRP) will be assessed at baseline (before rosuvastatin or placebo initiation), following 6 months, 12 months (study day 365), 18 months (study ...
14
Cohort study of the impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
... However, virological response with all oral DAAs in decompensated cirrhosis, particularly in HCV genotype 3, is lower than in patients with less advanced liver disease ...
37
Improving treatment and liver fibrosis outcomes with metformin in HCV HIV co infected and HCV mono infected patients with insulin resistance: study protocol for a randomized controlled trial
... (i) virological response rates (SVR 12 weeks post HCV anti- viral therapy) will be compared between treatment groups; (ii) the change in APRI measurements from baseline to start of HCV treatment, to the end ...
10